Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
Some patients treated with nirmatrelvir-ritonavir have experienced rebound of COVID-19 infections and symptoms; however, data are scarce on whether viral rebound also occurs in patients with COVID-19 receiving or not receiving molnupiravir.To examine the incidence of viral rebound in patients with C...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | angličtina |
| Vydáno: |
2022
|
| On-line přístup: | https://doi.org/10.1001/jamanetworkopen.2022.45086 https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2799218/wong_2022_oi_221276_1669731214.59609.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|